237 related articles for article (PubMed ID: 22564711)
1. Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity.
Wood DM; Dargan PI
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):227-33. PubMed ID: 22564711
[TBL] [Abstract][Full Text] [Related]
2. [Mephedrone: a designer drug of recent use in France].
Debruyne D; Courné MA; Le Boisselier R; Djezzar S; Gérardin M; Boucher A; Karila L; Coquerel A; Mallaret M
Therapie; 2010; 65(6):519-24. PubMed ID: 21176758
[TBL] [Abstract][Full Text] [Related]
3. Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances.
Wood DM; Dargan PI
Ther Drug Monit; 2012 Aug; 34(4):363-7. PubMed ID: 22673201
[TBL] [Abstract][Full Text] [Related]
4. Evidence of mephedrone chronic abuse through hair analysis using GC/MS.
Martin M; Muller JF; Turner K; Duez M; Cirimele V
Forensic Sci Int; 2012 May; 218(1-3):44-8. PubMed ID: 22041623
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
Dargan PI; Sedefov R; Gallegos A; Wood DM
Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
[TBL] [Abstract][Full Text] [Related]
6. Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats.
Motbey CP; Hunt GE; Bowen MT; Artiss S; McGregor IS
Addict Biol; 2012 Mar; 17(2):409-22. PubMed ID: 21995495
[TBL] [Abstract][Full Text] [Related]
7. Mephedrone, new kid for the chop?
Winstock AR; Mitcheson LR; Deluca P; Davey Z; Corazza O; Schifano F
Addiction; 2011 Jan; 106(1):154-61. PubMed ID: 20735367
[TBL] [Abstract][Full Text] [Related]
8. Mephedrone use among same-sex attracted young people in Sydney, Australia.
Lea T; Reynolds R; De Wit J
Drug Alcohol Rev; 2011 Jul; 30(4):438-40. PubMed ID: 21450044
[TBL] [Abstract][Full Text] [Related]
9. Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs.
Wood DM; Dargan PI
J Med Toxicol; 2012 Sep; 8(3):300-3. PubMed ID: 22581465
[TBL] [Abstract][Full Text] [Related]
10. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
Hadlock GC; Webb KM; McFadden LM; Chu PW; Ellis JD; Allen SC; Andrenyak DM; Vieira-Brock PL; German CL; Conrad KM; Hoonakker AJ; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2011 Nov; 339(2):530-6. PubMed ID: 21810934
[TBL] [Abstract][Full Text] [Related]
11. Mephedrone toxicity in a Scottish emergency department.
Regan L; Mitchelson M; Macdonald C
Emerg Med J; 2011 Dec; 28(12):1055-8. PubMed ID: 21183522
[TBL] [Abstract][Full Text] [Related]
12. Case series of individuals with analytically confirmed acute mephedrone toxicity.
Wood DM; Davies S; Greene SL; Button J; Holt DW; Ramsey J; Dargan PI
Clin Toxicol (Phila); 2010 Nov; 48(9):924-7. PubMed ID: 21171849
[TBL] [Abstract][Full Text] [Related]
13. Clinical Pharmacology of the Synthetic Cathinone Mephedrone.
Papaseit E; Moltó J; Muga R; Torrens M; de la Torre R; Farré M
Curr Top Behav Neurosci; 2017; 32():313-331. PubMed ID: 28012094
[TBL] [Abstract][Full Text] [Related]
14. [Mephedrone: a new synthetic drug].
Petit A; Karila L; Sananes M; Lejoyeux M
Presse Med; 2013 Oct; 42(10):1310-6. PubMed ID: 23669315
[TBL] [Abstract][Full Text] [Related]
15. Substitutional potential of mephedrone: an analysis of the subjective effects.
Kapitány-Fövény M; Kertész M; Winstock A; Deluca P; Corazza O; Farkas J; Zacher G; Urbán R; Demetrovics Z
Hum Psychopharmacol; 2013 Jul; 28(4):308-16. PubMed ID: 23881878
[TBL] [Abstract][Full Text] [Related]
16. Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.
McElrath K; O'Neill C
Int J Drug Policy; 2011 Mar; 22(2):120-7. PubMed ID: 21242082
[TBL] [Abstract][Full Text] [Related]
17. Instability of the ecstasy market and a new kid on the block: mephedrone.
Brunt TM; Poortman A; Niesink RJ; van den Brink W
J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554
[TBL] [Abstract][Full Text] [Related]
18. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.
Schifano F; Albanese A; Fergus S; Stair JL; Deluca P; Corazza O; Davey Z; Corkery J; Siemann H; Scherbaum N; Farre' M; Torrens M; Demetrovics Z; Ghodse AH; ;
Psychopharmacology (Berl); 2011 Apr; 214(3):593-602. PubMed ID: 21072502
[TBL] [Abstract][Full Text] [Related]
19. Dependence and psychosis with 4-methylmethcathinone (mephedrone) use.
Bajaj N; Mullen D; Wylie S
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791836
[TBL] [Abstract][Full Text] [Related]
20. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
Wood DM; Greene SL; Dargan PI
Emerg Med J; 2011 Apr; 28(4):280-2. PubMed ID: 20581379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
